Cholecystokinin (CCK) is a peptide originally discovered in the gastrointes
tinal tract but also found in high density in the mammalian brain. The C-te
rminal sulphated octapeptide fragment of cholecystokinin (CCK8) constitutes
one of the major neuropeptides in the brain; CCK8 has been shown to be inv
olved in numerous physiological functions such as feeding behavior, central
respiratory control and cardiovascular tonus, vigilance states, memory pro
cesses, nociception, emotional and motivational responses.
CCK8 interacts with nanomolar affinities with two different receptors desig
nated CCK-A and CCK-B. The functional role of CCK and its binding sites in
the brain and periphery has been investigated thanks to the development of
potent and selective CCK receptor antagonists and agonists.
In this review, the strategies followed to design these probes, and their u
se to study the anatomy of CCK pathways, the neurochemical and pharmacologi
cal properties of this peptide and the clinical perspectives offered by man
ipulation of the CCK system will be reported. The physiological and patholo
gical implication of CCK-B receptor will be confirmed in CCK-B receptor def
icient mice obtained by gene targeting (Nagata et al,, 1996. Proc. Natl. Ac
ad. Sci. USA 93, 11825-11830). Moreover, CCK receptor gene structure, delet
ion and mutagenesis experiments, and signal transduction mechanisms will be
discussed. (C) 1999 Elsevier Science Ltd. All rights reserved.